- 學位論文
橙皮素在活體及離體抗氣喘的作用機轉
Machanisms of anti-asthmatic action of hesperetin in vivo and in vitro Machanisms of anti-asthmatic action of hesperetin in vivo and in vitro
摘要
part I 橙皮素 (hesperein) 是一種選擇性PDE4的抑制劑，然其是否有治療氣喘的作用，目前還未有研究，因此是本篇研究的目的。 本實驗將 BALB/c 小鼠腹腔內注射卵蛋白 (ovalbumin; OVA) ，使其敏感化，再以卵蛋白 (OVA) 氣化噴霧刺激 (secondary challenge) ，利用整體體積描述器來分析因 methacholine (MCh) 引起的氣道過度反應 (airway hyperresponsiveness response; AHR)，結果顯示 hesperetin 能抑制卵蛋白 (OVA) 引起的氣道過度反應 (AHR)，hesperetin (10~30 ?mol/kg, i.p.) 亦能依劑量相關性且有意義地減少 MCh (25~50 mg/ml) 引起的 Penh 值增加。投與hesperetin (3~30 ?mol/kg, i.p.) 的小白鼠與暴露於 OVA 氣化噴霧但未敏感化 (non-sensitized) 之小白鼠無異。觀察肺泡灌流液 (BALF) 的細胞沉澱物，發現 hesperetin (10~30 ?mol/kg, i.p.) 具有統計意義地 (P < 0.05) 減少總發炎細胞數、嗜中性血球、嗜伊紅白血球、淋巴球及巨噬細胞。Hesperetin (3~30 ?mol/kg, ip) 有統計意義地 (P < 0.05) 降低 IL-2, IL-4, IFN-? 和 TNF-? 的釋放，當劑量高達 30 ?mol/kg 時更可顯著地抑制 IL-5 的釋放 (P ＜ 0.05)。Hesperetin (30 ?M) 有意義地抑制累加之 OVA (10~100 ?g/ml) 所造成敏感化離體天竺鼠氣管的收縮。由 Lineweaver-Burk 分析發現 hesperetin (10~100 ?M) 對PDE4 呈競爭性的抑制作用。結論，hesperetin 具選擇性且競爭性地抑制 PDE4，在所用劑量 (10~30 ?mol/kg, i.p.) 具抗發炎及支氣管擴張的作用，因此推測hesperetin極具治療氣喘的潛力。 Part II 西方各國均認為選擇性的PDE4抑制劑是治療氣喘及慢性阻塞性肺病的希望，只可惜會結合到腦的rolipram高親和力的結合點 (HARBS)，而造成嘔吐及胃酸分泌的副作用。有些類黃鹼素也對PDE4具選擇性的抑制作用，因此有必要了解它們在腦部顆粒HARBS結合的情形，以篩選出治療氣喘有用的藥物。 敏感化與未敏感化的天竺鼠全腦細胞顆粒 HARBS，以Scatchard plots分析，結果顯示兩者之間之Bmax在統計上並無差別。 本文結果顯示luteolin及genistein會依濃度相關性地取代結合在敏感化天竺鼠全腦細胞顆粒HARBS之 [3H]-rolipram，其EC50值分別為11.2及47.7 ?M，其他所測定的類黃鹼素其EC50值均超過300 ?M。因diosmetin之EC50值大於luteolin，顯示C-4?之 OH基被甲基化之後就比較不會與HARBS結合。而luteolin-7-glucoside之EC50值大於luteolin，推測C-7之OH基被醣化後形成的龐大體積，使其不易與腦部的HARBS結合。Biochanin A或prunetin之EC50值均大於genistein，顯示C-4?或C-7之OH基甲基化後，較難與 HARBS結合。 Biochanin A的PDE4H/PDE4L比大於35，不過biochanin A對PDE1及PDE2也有抑制的作用，對PDE4的選擇性相對較弱。Hesperetin 和hesperetin triacetate的PDE4H/PDE4L比分別為11和12，其中hesperetin可選擇性的抑制PDE4，它們或許能成為治療氣喘及慢性阻塞性肺病的藥物。
並列摘要
Part I Hesperetin selectively inhibits PDE4. To evaluate whether it possesses anti-asthmatic effect is the aim of this investigation. Female BALB/c mice were sensitized by an intraperitoneal injection of ovalbumin (OVA), then challenged two times via the airway by ultrasonic nebulization of 1% OVA. After secondary challenge, the airway hyperresponsiveness was measured in unrestrained animals nebulized methacholine (MCh, 6.25~50 mg/ml), by barometric plethysmography using a whole-body plethysmograph. Hesperetin (10~30 μmol/kg, i.p.) revealed it dose-dependently and significantly attenuated the enhanced pause (Penh) value induced by MCh (25~50 mg/ml). The Penh values of mice administered hesperetin (3~30 μmol/kg, i.p.) did not significantly differ from those challenged by OVA without sensitization mice (non-sensitized). Hesperetin (10~30 μmol/kg, i.p.) also significantly inhibited total inflammatory cells, macrophages, lymphocytes, neutrophils, eosinophils,in bronchoalveolar lavage fluid (BALF). Hesperetin (10~30 μmol/kg, i.p.) also significantly attenuated the release of IL-2, IL-4, IFN-γ and TNF-α. It at a dose of 30 μmol/kg further significantly inhibited the release of IL-5. Hesperetin (30 μM) significantly inhibited cumulative OVA (10~100 μg/ml)-induced contractions of isolated sensitized guinea pig trachea. By Lineweaver-Burk analysis, hesperetin (10~100 μM) competitively inhibited PDE4 activities. In conclusion, hesperetin selectively and competitively inhibited PDE4 activities. At doses of 10~30 μmol/kg (i.p.), it possessed anti-inflammatory and bronchodilating effects. Therefore it may have potential in the treatment of asthma. Part II In western countries , it is realized a hope that selective PDE4 inhibitors may be used in the treatment of asthma and chronic obstructive pulmonary disease. However , they may bind to brain high affinity rolipram binding sites (HARBS) from which some side effects, such as vomiting and gastric hypersecretion, are developed. Some flavonoids also selectively inhibit PDE4, therefore it is nessary to understand their binding on the HARBS of brain particulate and to screen out useful drugs. By Scatchard polt analysis, it revealed that Bmax values of HARBS of sensitized and non-sensitized guinea pig brain particulate did not significantly differ from each other. In the present result, luteolin and genistein concentration-dependently displaced [3H]-rolipram bound on the HARBS of the sensitized guinea pig whole brain particulate. Their EC50 values were 11.24 and 47.75 ?M, respectively. Those of other flavonoids used were beyond 300 ?M. It revealed that the methylation on C-4?OH group of flavones reduced the binding on the HARBS, because the EC50 values of diosmetin was greater than that of luteolin. It also showed glycosylation on C-7 group of flavones may reduced the binding on the HARBS, because the EC50 value of luteolin-7-glucoside was greater than that of luteolin. It also revealed that the methylation on C-4?or C-7 OH group of isoflavones may reduced the binding on the HARBS, because both EC50 values of biochanin A and prunetin were greater than that genistein. The PDE4H/PDE4L ratio of biochanin A was greater than 35, but it also inhibited PDE1 and PDE2. In other words, its selectivity on PDE4 inhibition was not so high. However, those of hesperetin and hesperetin triacetate were 11 and 12, respectively. They selectively inhibited PDE4, therefore they may become therapeutic drugs for the treatment of asthma and chronic obstructive pulmonary disease.
參考文獻
延伸閱讀
- 王文弘（2006）。5,7,3'-三甲基橙皮素的抗氣喘作用與初、後期氣喘 動物模式之探討〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1704200715053513
- 黃惠琳（2004）。槲皮素在活體及離體抗氣喘的作用機轉〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1704200714562989
- 韓政穎（2007）。7,3'-O-二甲基橙皮素抗氣喘的作用〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1807200716125900
- 章育銘（2020）。柚皮素對於抑制肺癌以及骨肉瘤細胞轉移的分子機轉〔博士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/CSMU202000012
- Shtukmaster, S., Ljubuncic, P., & Bomzon, A. (2010). The Effect of an Aqueous Extract of Teucrium polium on Glutathione Homeostasis In Vitro: A Possible Mechanism of Its Hepatoprotectant Action. Advances in Pharmacological Sciences, 2010(), 59-65. https://doi.org/10.1155/2010/938324